Impact of Certolizumab Pegol on Patient-Reported Outcomes in Patients With Axial Spondyloarthritis

J. Sieper*, A. Kivitz, A. van Tubergen, A. Deodhar, G. Coteur, F. Woltering, R. Landewé

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Impact of Certolizumab Pegol on Patient-Reported Outcomes in Patients With Axial Spondyloarthritis'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

INIS